APA (7th ed.) Citation

Nguyen, O. T. P., Lara, S., Ferro, G., Peipp, M., & Kleinau, S. Rituximab-IgG2 is a phagocytic enhancer in antibody-based immunotherapy of B-cell lymphoma by altering CD47 expression. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Nguyen, Oanh T. P., Sandra Lara, Giovanni Ferro, Matthias Peipp, and Sandra Kleinau. Rituximab-IgG2 Is a Phagocytic Enhancer in Antibody-based Immunotherapy of B-cell Lymphoma by Altering CD47 Expression. Frontiers Media S.A.

MLA (9th ed.) Citation

Nguyen, Oanh T. P., et al. Rituximab-IgG2 Is a Phagocytic Enhancer in Antibody-based Immunotherapy of B-cell Lymphoma by Altering CD47 Expression. Frontiers Media S.A.